"Teamwork Makes the Dream Work": Initial Evidence for Enhancing Problem-Solving in Rural Heart Failure Dyads.

J Cardiovasc NursFeb 17, 2026 (epub)
Clinical ResearchCardiologyPsychiatry

Lucinda J Graven, Thomas Ledermann, Erin Stearns et al.

✦ AI-curated · Sources linked

In 30 seconds

This dyadic single-group repeated-measures study assessed the feasibility and preliminary effects of a tailored, telephone-based problem-solving intervention in 41 rural heart failure patient–care partner dyads. Participants completed eight sessions addressing heart failure-related problems, with outcomes measured at baseline and 5, 9, and 13 weeks. Patients showed significant improvements in problem-solving (b = 0.45, P < .001), self-care maintenance (b = 2.29, P < .001), and depressive symptoms (b = -1.81, P = .002). Self-care confidence increased significantly in both patients and care partners. The authors call for evaluation in a larger clinical trial.

Key findings

  • Patient problem-solving improved significantly (b = 0.45, P < .001).
  • Patient self-care maintenance improved (b = 2.29, P < .001), and depressive symptoms decreased (b = -1.81, P = .002).
  • Self-care confidence increased in patients (b = 2.51, P < .001) and care partners (b = 2.26, P = .01).

Why it matters

Heart failure self-care can place emotional and practical demands on both patients and care partners, particularly in rural settings. These preliminary findings suggest that structured telephone sessions focused on shared problem-solving may support patient self-care and mood while also strengthening confidence in both members of the dyad. The study highlights a potentially useful approach for further evaluation, rather than establishing effectiveness.

What to keep in mind

The single-group design without a comparator limits conclusions about whether the intervention caused the observed changes. The authors state that a larger clinical trial is needed.

Source

Published in J Cardiovasc Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.